Autoimmune hemolytic anemia in patients with liver transplants for primary biliary cirrhosis: Three case reports and a review of the literature

American Journal of Gastroenterology

Volumn 102, Issue 1, 2007, Pages 197-200

  Retana, Alexandra K ^a   Kaplan, Marshal M ^a   Erban, John K ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; CALCIUM CARBONATE; CIPROFLOXACIN; CLOPIDOGREL; COTRIMOXAZOLE; DIGOXIN; ENOXAPARIN; FOLIC ACID; FUROSEMIDE; IMMUNOGLOBULIN; IRON; LEVOTHYROXINE; LOW MOLECULAR WEIGHT HEPARIN; MAGNESIUM OXIDE; METHYLPREDNISOLONE; METOPROLOL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PANTOPRAZOLE; PREDNISONE; QUININE SULFATE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RITUXIMAB; SIMVASTATIN; SOTALOL; STEROID; TACROLIMUS; URSODEOXYCHOLIC ACID; WARFARIN;

ADULT; AGED; ARTERY THROMBOSIS; ARTICLE; AUTOIMMUNE HEMOLYTIC ANEMIA; BACTEREMIA; BUDD CHIARI SYNDROME; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DYSPNEA; ENDOSCOPY; FATIGUE; FEBRILE NEUTROPENIA; FEMALE; GRAFT REJECTION; HEMATOCRIT; HEMICOLECTOMY; HEMOLYSIS; HUMAN; HUMAN TISSUE; IDIOPATHIC THROMBOCYTOPENIC PURPURA; IMMUNOASSAY; LABORATORY TEST; LIVER BIOPSY; LIVER GRAFT; MALE; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL; RETICULOCYTE COUNT; SPLENECTOMY; TREATMENT RESPONSE;

AGED; ANEMIA, HEMOLYTIC, AUTOIMMUNE; FATAL OUTCOME; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LIVER CIRRHOSIS, BILIARY; LIVER TRANSPLANTATION; MALE; MIDDLE AGED;

EID: 33846098281     PISSN: 00029270     EISSN: 15720241     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2006.00810.x     Document Type: Article

References (13)

1. Kaplan MM, Gershwin ME. Primary biliary cirrhosis. N Engl J Med 2005;353:1261-73.
2. Gehrs BC, Friedberg RC. Autoimmune hemolytic anemia. Am J Hematol 2002;69:258-71.
3. Culp KS, Fleming CR, Duffy J, et al. Autoimmune associations in primary biliary cirrhosis. Mayo Clin Proc 1982;57:365-70.
4. Hanto DW, Fecteau AH, Alonso MH, et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation. Liver Transpl 2003;9:22-30.
5. Clavien PA, Camargo CA, Cameron R, et al. Kupffer cell erythrophagocytosis and graft-versus-host hemolysis in liver transplantation. Gastroenterology 1996;110:1891-6.
6. Smith DM, Agura E, Netto G, et al. Liver transplant associated graft-versus-host disease. Transplantation 2003;75:118-26.
7. Danesi R, Del Tacca M. Hematologic toxicity of immunosuppressive treatment. Transplant Proc 2004;36:703-4.
8. Emre S, Genyk Y, Schluger LK, et al. Treatment of tacrolimus-related adverse effects by conversion to cyclosporine in liver transplant recipients. Transplant Int 2000;13:73-8.
9. Kitamura T, Mizuta K, Kawarasaki H, et al. Severe hemolytic anemia related to production of cold agglutinins following living donor liver transplantation: A case report. Transplant Proc 2003;35:399-400.
10. DiGiuseppe JA, Bastacky SI, Shirey RS, et al. Tacrolimus-related post-transplant lymphoproliferative disorder presenting as autoimmune hemolytic anemia. Arch Pathol Lab Med 1996;120:282-5.
11. Lelievre JD, Sacre K, Adle-Biassette H, et al. Epstein-Barr virus associated lymphoproliferative disease after long standing cyclosporine therapy: A case of spontaneous regression. J Am Acad Dermatol 2005;52:S24-7.
12. Horwitz, CA. Autoimmune hemolytic anemia 2. Drug-induced type. Postgrad Med 1979;66:199-202.
13. Bennett CL, Connors JM, Carwile JM, et al. Thrombotic thrombocytopenic purpura associated with clopidogrel. N Engl J Med 2000;342:1773-7.